Brookfield Corp’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18,798
| Closed | -$1.63M | – | 171 |
|
|
2023
Q2 | $1.63M | Sell |
18,798
-118,545
| -86% | -$10.3M | 0.01% | 414 |
|
|
2023
Q1 | $13.4M | Sell |
137,343
-38,302
| -22% | -$3.72M | 0.05% | 132 |
|
|
2022
Q4 | $18.2M | Buy |
175,645
+29,330
| +20% | +$3.04M | 0.07% | 97 |
|
|
2022
Q3 | $12.4M | Sell |
146,315
-12,541
| -8% | -$1.06M | 0.05% | 138 |
|
|
2022
Q2 | $13.2M | Sell |
158,856
-31,272
| -16% | -$2.59M | 0.06% | 115 |
|
|
2022
Q1 | $14.7M | Buy |
190,128
+95,426
| +101% | +$7.36M | 0.05% | 114 |
|
|
2021
Q4 | $8.37M | Buy |
94,702
+26,930
| +40% | +$2.38M | 0.03% | 140 |
|
|
2021
Q3 | $5.24M | Sell |
67,772
-14,255
| -17% | -$1.1M | 0.02% | 210 |
|
|
2021
Q2 | $6.84M | Buy |
82,027
+10,839
| +15% | +$904K | 0.03% | 170 |
|
|
2021
Q1 | $5.38M | Buy |
71,188
+18,281
| +35% | +$1.38M | 0.03% | 153 |
|
|
2020
Q4 | $4.64M | Buy |
+52,907
| New | +$4.64M | 0.02% | 168 |
|